Last Updated on December 25, 2024 by The Health Master
Bulk drug import
India’s pharmaceutical industry, a global powerhouse, has been striving to reduce its Bulk drug import from China.
However, recent data reveals a concerning trend: India’s Bulk drug import, active pharmaceutical ingredients (APIs) and drug intermediates from China have surged in the past five years.
Key Findings:
- Significant Import Growth: India’s bulk drug import from China have increased by a substantial 64.5% in Rupee terms between 2019-20 and 2023-24.
- Dominance of Chinese Imports: China remains a major supplier of pharmaceutical raw materials to India, accounting for a significant portion of the overall imports.
- Persistent Growth: Despite fluctuations in global markets, India’s imports from China have shown consistent growth, with only minor declines in recent quarters.
- Quantity Surge: The volume of bulk drug import from China has also increased significantly, highlighting India’s growing dependence on Chinese suppliers.
Government Initiatives to Reduce Bulk drug import:
The Indian government has implemented various schemes and initiatives to promote domestic manufacturing of APIs and drug intermediates, including the Production Linked Incentive (PLI) scheme.
These efforts aim to reduce India’s reliance on foreign imports and strengthen its domestic pharmaceutical supply chain.
Key Takeaways:
- India’s pharmaceutical industry remains heavily reliant on Chinese imports.
- Government initiatives are underway to reduce this dependence.
- Domestic manufacturing and supply chain resilience are crucial for India’s pharmaceutical sector.
By addressing these challenges and implementing effective strategies, India can reduce its reliance on Chinese imports and secure a sustainable future for its pharmaceutical industry.
1. Why is India dependent on China for pharmaceutical imports?
India’s pharmaceutical industry heavily relies on China for a variety of reasons, including cost-effectiveness, quality, and a well-established supply chain.
2. What are the risks associated with relying on Chinese imports?
Excessive reliance on Chinese imports can expose India to supply chain disruptions, geopolitical tensions, and potential quality control issues.
3. How can India reduce its dependence on Chinese imports?
To reduce its dependence on Chinese imports, India needs to focus on strengthening its domestic manufacturing capabilities, investing in research and development, and creating a conducive regulatory environment for the pharmaceutical industry.
Disclaimer: This article contains information derived from the source mentioned below. Our team utilized an AI language model to rewrite and present the news or article in a unique format.
Anti dumping investigation on Aniline imports from China
China’s drug regulator approves MPOX vaccine for Clinical Trial
Over 340 Pharma Companies overdue for USFDA inspection in India and China
Stay action against Pharma units manufacturing Nutraceuticals: High Court
NPPA fixed retail price of 7 formulations: December 2024
Revised Schedule M: Industry seeks balance between Quality and Viability
FDA Karnataka enters a New Era of Food and Drug Safety
Key Notes on Revised Schedule M: Point No. 13 – Equipment
GST Penalty of Rs. 1.11 Crore on Cipla
FSSAI regulations on use of Methylcobalamin in Supplements
FOPE demands inclusion of Sensitive drugs in Schedule P
For informative videos by The Health Master, click on the below YouTube icon:
For informative videos on Medical Store / Pharmacy, click on the below YouTube icon:
For informative videos on the news regarding Pharma / Medical Devices / Cosmetics / Homoeopathy etc., click on the below YouTube icon:
For informative videos on consumer awareness, click on the below YouTube icon:
